Featured Speaker: Bita Esmaeli, MD, FACS, University of Texas MD Anderson Cancer Center
Topic: Oculoplastic Surgery
Host: Keith D. Carter, MD and Richard Allen, MD, PhD

Contact Person: Pat Zahs at 319-356-4475 or via e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

---

MEETING SCHEDULE:

8:45 AM Lecture: Management of Eyelid and Conjunctival Melanoma: Local treatments, Adjuvant treatments and Sentinel Lymph node biopsy

9:30 AM Case Presentations and Discussions

10:30 AM Break

11:00 AM Case Presentations and Discussions

12:00 PM Lunch

1:00 PM Lecture: Eyelid tumors: Clinical Pearls

1:20 PM Lecture: Nasolacrimal Duct Obstruction and DCR Surgery in Cancer Patients

Bita Esmaeli, MD, FACS, is a Professor of Ophthalmology at The University of Texas M. D. Anderson Cancer Center, where she developed an orbital oncology and oncologic oculoplastic surgery practice since 1998.

Dr. Esmaeli was instrumental in establishing the Ophthalmology Section as a comprehensive full-time service at M. D. Anderson Cancer Center in 1998. She served as the Director of the Ophthalmologic Services from 1998 to 2001 and as the Chief of the Ophthalmology Section at M. D. Anderson from 2001 to 2004. She is the Program Director for an ASOPRS-sponsored and ACGME-approved fellowship in oculoplastic surgery and orbital oncology at M. D. Anderson Cancer Center.

Dr Esmaeli has authored over 120 peer-reviewed manuscripts, over 50 invited articles and book chapters, has spearheaded several clinical trials and has participated in numerous research protocols at M. D. Anderson Cancer Center. She has received many prestigious awards and honors including the Merrill Reeh Pathology Award and the Research Award from the American Society of Ophthalmic Plastic and Reconstructive Surgery, the American Academy of Ophthalmology Achievement Award, Best Doctors in America, and Top Doctors Award.

Dr Esmaeli 's clinical practice focuses on the surgical treatment of tumors of the eyelid, orbit, and conjunctiva, complex reconstructive surgery in the periocular region, and lacrimal surgery.

Objectives: Upon completion of this conference, participants should:

1. Be able to correctly diagnose conjunctival and eyelid melanomas and understand the importance of biopsy techniques.
2. Be able to recognize the most common chemotherapy drugs that can cause canalicular and nasolacrimal duct blockage.
3. Be able to avoid mistaking an eyelid malignancy for the more common inflammatory or infectious etiology.